Yasushi Shiratori

Yasushi Shiratori's AcademicInfluence.com Rankings

Yasushi Shiratori

Philosophy

#8797

World Rank

#12245

Historical Rank

Logic

#5815

World Rank

#7255

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Yasushi Shiratori's Degrees

PhD Medicine University of Tokyo

Why Is Yasushi Shiratori Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Yasushi Shiratori's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan (1999) (1092)
Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy (2000) (741)
An Experimental Study in Dogs (1990) (708)
A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. (2005) (452)
Characteristic difference of hepatocellular carcinoma between hepatitis B‐ and C‐ viral infection in Japan (1995) (374)
Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. (1993) (373)
Virulence Factors of Helicobacter pylori Responsible for Gastric Diseases in Mongolian Gerbil (2000) (310)
Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. (1996) (307)
Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study (1991) (291)
Des‐γ‐carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma (2001) (283)
Antiviral Therapy for Cirrhotic Hepatitis C: Association with Reduced Hepatocellular Carcinoma Development and Improved Survival (2005) (280)
Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus (2003) (273)
Major virulence factors, VacA and CagA, are commonly positive inHelicobacter pylori isolates in Japan (1998) (272)
The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. (2001) (272)
Differences between right‐ and left‐sided colon cancer in patient characteristics, cancer morphology and histology (2008) (258)
Interferon therapy prolonged life expectancy among chronic hepatitis C patients. (2002) (243)
Endoscopic submucosal dissection for early gastric cancer: results and degrees of technical difficulty as well as success. (2006) (239)
The Effect of Eradicating Helicobacter Pylori on the Development of Gastric Cancer in Patients with Peptic Ulcer Disease (2005) (230)
Distinct Mechanism of Helicobacter pylori-mediated NF-κB Activation between Gastric Cancer Cells and Monocytic Cells* (2001) (210)
Cyclins and cyclin‐dependent kinases: Comparative study of hepatocellular carcinoma versus cirrhosis (2003) (206)
Activation of intracellular signaling by hepatitis B and C viruses: C‐viral core is the most potent signal inducer (2000) (204)
In vivo gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene. (1997) (192)
Predictors of the efficacy of interferon therapy in chronic hepatitis C virus infection. Tokyo-Chiba Hepatitis Research Group. (1997) (191)
H. pylori activates NF-κB through a signaling pathway involving IκB kinases, NF-κB—inducing kinase, TRAF2, and TRAF6 in gastric cancer cells☆ (2000) (183)
Structure of cag pathogenicity island in Japanese Helicobacter pyloriisolates (1999) (178)
YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitrofull‐length viral DNA transfection (1999) (172)
Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C (2006) (170)
Hepatitis C Virus Core Protein Enhances p53 Function through Augmentation of DNA Binding Affinity and Transcriptional Ability* (2000) (170)
Involvement of the biliary system in autoimmune pancreatitis: a follow-up study. (2003) (167)
Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C (2004) (158)
Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator. (1997) (158)
Interleukin‐1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection (2003) (157)
Sensitivity and Specificity of Des-Gamma-Carboxy Prothrombin for Diagnosis of Patients with Hepatocellular Carcinomas Varies According to Tumor Size (2006) (154)
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. (2005) (150)
Polyurethane-covered metal stent for management of distal malignant biliary obstruction. (2002) (146)
Detection of α‐fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: A possible predictor of metastatic hepatocellular carcinoma (1994) (136)
Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors. (1999) (134)
Percutaneous ethanol injection therapy of hepatocellular carcinoma: analysis of 77 patients. (1990) (129)
Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation (2004) (129)
Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus—An analysis of 236 consecutive patients with a single lesion (2000) (129)
Gene therapy for α‐fetoprotein‐producing human hepatoma cells by adenovirus‐mediated transfer of the herpes simplex virus thymidine kinase gene (1996) (125)
Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. (1997) (125)
Fetal microchimerism alone does not contribute to the induction of primary biliary cirrhosis (1999) (124)
Modulation of hepatotoxicity by macrophages in the liver (1988) (123)
A Comparison of the Immunochemical Fecal Occult Blood Test and Total Colonoscopy in the Asymptomatic Population (2005) (123)
Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type (2007) (116)
Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro. (1996) (115)
Hepatitis C Virus Core Protein Activates Nuclear Factor κB-dependent Signaling through Tumor Necrosis Factor Receptor-associated Factor* (2001) (114)
High incidence of ADH2*1/ALDH2*1 genes among Japanese alcohol dependents and patients with alcoholic liver disease (1996) (114)
Increased Nitric Oxide in the Exhaled Air of Patients with Decompensated Liver Cirrhosis (1995) (114)
Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. (1998) (110)
Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor (2002) (110)
Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil. (1998) (108)
Mutational Inactivation of Mitotic Checkpoint Genes, hsMAD2 and hBUB1, Is Rare in Sporadic Digestive Tract Cancers (1999) (106)
Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells (2001) (105)
Hepatitis C virus core protein upregulates transforming growth factor‐β1 transcription (2004) (105)
Endoscopic papillary balloon dilation in cirrhotic patients: removal of common bile duct stones without sphincterotomy. (1996) (102)
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori (2002) (102)
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma (2011) (101)
Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects (2001) (100)
Stromal Cell–Derived Factor-1 from Biliary Epithelial Cells Recruits CXCR4-Positive Cells: Implications for Inflammatory Liver Diseases (2003) (97)
Helicobacter pylori heat-shock protein 60 induces inflammatory responses through the Toll-like receptor-triggered pathway in cultured human gastric epithelial cells. (2004) (95)
Des-γ-carboxy Prothrombin Is a Potential Autologous Growth Factor for Hepatocellular Carcinoma* (2005) (93)
Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations. (2006) (91)
Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis. (2005) (90)
Kupffer cells from CCl4-induced fibrotic livers stimulate proliferation of fat-storing cells. (1986) (90)
α‐Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: A prospective study (2002) (89)
Detection of Clarithromycin-ResistantHelicobacter pylori Strains by a Preferential Homoduplex Formation Assay (2000) (89)
cDNA microarray analysis of Helicobacter pylori-mediated alteration of gene expression in gastric cancer cells. (2001) (88)
Helicobacter pylori Activates the Cyclin D1 Gene through Mitogen- Activated Protein Kinase Pathway in Gastric Cancer Cells (2001) (87)
In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. (1997) (87)
A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability. (1996) (86)
H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. (2000) (85)
Determination of Helicobacter pyloriVirulence by Simple Gene Analysis of the cagPathogenicity Island (2001) (84)
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. (2003) (82)
pp60c‐src Activation in hepatocellular carcinoma of humans and LEC rats (1998) (82)
Relationship between age and site of colorectal cancer based on colonoscopy findings. (2002) (82)
Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo (2002) (81)
Caspase induction by IgA antimitochondrial antibody: IgA‐mediated biliary injury in primary biliary cirrhosis (2004) (81)
Tumor-specific gene expression in carcinoembryonic antigen--producing gastric cancer cells using adenovirus vectors. (1996) (80)
Reduced C‐terminal Src kinase (Csk) activities in hepatocellular carcinoma (1999) (78)
Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? (1997) (77)
Eradication of Helicobacter pylori increases platelet count in patients with idiopathic thrombocytopenic purpura in Japan (2005) (77)
Helicobacter pylori CagA protein activates serum response element-driven transcription independently of tyrosine phosphorylation. (2002) (75)
Hepatitis C virus core protein upregulates transforming growth factor-beta 1 transcription. (2004) (73)
Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort. (2005) (73)
Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. (2006) (73)
Platelet count reflects stage of chronic hepatitis C (1999) (72)
Rapid Detection of Mutations in the 23S rRNA Gene of Helicobacter pylori That Confers Resistance to Clarithromycin Treatment to the Bacterium (2001) (71)
Sensitivity of Immunochemical Fecal Occult Blood Test to Small Colorectal Adenomas (2007) (70)
Simple surrogate index of the fibrosis stage in chronic hepatitis C patients using platelet count and serum albumin level. (2006) (70)
Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats. (2003) (68)
Interleukin-1β genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection (2003) (67)
Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor. (2002) (65)
Detection of GBV‐C RNA in patients with non‐A‐E fulminant hepatitis by reverse‐transcription polymerase chain reaction (1997) (65)
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance (1998) (65)
Thrombospondin-1 is Induced in Rat Myocardial Infarction and Its Induction is Accelerated by Ischemia/Reperfusion (2005) (65)
Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. (2002) (65)
Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy (2004) (64)
[13C]methacetin breath test for evaluation of liver damage (1987) (64)
Direct detection of Mycobacterium tuberculosis using polymerase chain reaction assay among patients with hepatic granuloma. (1997) (64)
Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. (2005) (64)
Versican is induced in infiltrating monocytes in myocardial infarction (2005) (63)
The evaluation of putative virulence factors of Helicobacter pylori for gastroduodenal disease by use of a short-term Mongolian gerbil infection model. (2002) (63)
Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy. (2005) (63)
Altered expression of vascular endothelial growth factor, fibroblast growth factor‐2 and endostatin in patients with hepatocellular carcinoma (2005) (61)
Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis. (2005) (61)
Cytokine‐induced neutrophil chemoattractant release from hepatocytes is modulated by Kupffer cells (1996) (61)
Role of endotoxin‐responsive macrophages in hepatic injury (1990) (61)
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des‐γ‐carboxy prothrombin and low serum α‐fetoprotein (2000) (61)
Original articleCharacteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan (1995) (59)
Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells. (2001) (59)
Relevance network between chemosensitivity and transcriptome in human hepatoma cells. (2003) (58)
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. (2002) (57)
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver (2003) (57)
Hepatocellular carcinoma cell cycle: Study of Long‐Evans Cinnamon rats (2000) (57)
Cost‐effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances (2008) (57)
Lamivudine treatment improves the prognosis of fulminant hepatitis B. (2008) (56)
Time-dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. (2005) (55)
Nested-polymerase chain reaction for the detection of Helicobacter pylori infection with novel primers designed by sequence analysis of urease A gene in clinically isolated bacterial strains. (1996) (55)
Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used (2000) (55)
Preserved function of the Oddi sphincter after endoscopic papillary balloon dilation. (2003) (54)
Extensive mesenteric vein and portal vein thrombosis successfully treated by thrombolysis and anticoagulation (2001) (54)
Decreased expression of B7 costimulatory molecules and major histocompatibility complex class‐I in human hepatocellular carcinoma (2004) (53)
Determination of Helicobacter pylori Virulence by Simple Gene Analysis of the cag Pathogenicity Island (2000) (52)
Thoracoscopic thermal ablation therapy for hepatocellular carcinoma located beneath the diaphragm. (2001) (52)
Modulation of ischemia-reperfusion-induced hepatic injury by kupffer cells (1994) (50)
Surveillance of hepatocellular carcinoma in patients with hepatitis C virus infection may improve patient survival (2006) (50)
Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation (2002) (49)
Use of a Gastric Juice-Based PCR Assay To DetectHelicobacter pylori Infection in Culture-Negative Patients (1998) (49)
Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood. (1995) (48)
Inflammatory pseudotumor of the liver and peripheral eosinophilia in autoimmune pancreatitis. (2005) (48)
Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar. (2004) (46)
Presence of α-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma (1999) (46)
Collagen production by rat liver fat-storing cells in primary culture. (1986) (46)
Adenovirus mediated p53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo (1999) (45)
Reduced C‐terminal Src kinase activity is correlated inversely with pp60c‐src activity in colorectal carcinoma (2001) (45)
Analysis of the β‐Catenin/T Cell Factor Signaling Pathway in 36 Gastrointestinal and Liver Cancer Cells (2002) (45)
Des-γ-carboxyl Prothrombin-promoted Vascular Endothelial Cell Proliferation and Migration* (2007) (45)
High prevalence of cytotoxin positive Helicobacter pylori in patients unrelated to the presence of peptic ulcers in Japan (1997) (44)
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-gamma-carboxy prothrombin and low serum alpha-fetoprotein. (2000) (44)
Quantification of sinusoidal cell function in vivo. (1993) (44)
Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000 (2007) (44)
Production of chemotactic factor, interleukin‐8, from hepatocytes exposed to ethanol (1993) (43)
Target gene therapy for alpha-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus. (2001) (43)
High Seropositivity of Anti-CagA Antibody in Helicobacter pylori-Infected Patients Irrelevant to Peptic Ulcers and Normal Mucosa in Japan (1997) (43)
Quantitative assays for hepatitis C virus in serum as predictors of the long-term response to interferon. (1997) (43)
Weak Association between SEN Virus Viremia and Liver Disease (2002) (42)
Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. (2007) (42)
High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions (1999) (41)
Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. (1997) (41)
ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model (2006) (40)
Tumor‐specific expression of the RGD‐α3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice (2006) (40)
Quantitation of alpha-fetoprotein and albumin messenger RNA in human hepatocellular carcinoma. (1996) (40)
Novel Nucleoside Analogue MCC-478 (LY582563) Is Effective against Wild-Type or Lamivudine-Resistant Hepatitis B Virus (2002) (38)
Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. (2004) (38)
Expression of p57KIP2 in hepatocellular carcinoma: relationship between tumor differentiation and patient survival (2002) (37)
Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features (2007) (37)
Analysis of apoptotic and antiapoptotic signalling pathways induced by Helicobacter pylori (2002) (37)
Prospective study of interferon therapy for compensated cirrhotic patients with chronic hepatitis C by monitoring serum hepatitis C RNA (1999) (36)
Risk Factors and Indications for Colectomy in Ulcerative Colitis Patients are Different According to Patient’s Clinical Background (2006) (36)
The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine. (2004) (36)
Clinical features of Japanese elderly patients with type 1 autoimmune hepatitis. (2007) (36)
Endoscopic sphincterotomy and papillary balloon dilation for bile duct stones. (2005) (35)
Kupffer cell function in chronic ethanol-fed rats. (2008) (35)
Flat-Type Early Colorectal Cancer Preferentially Develops in Right-Sided Colon in Older Patients (2005) (35)
Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis (2007) (34)
Histological analysis of the papilla after endoscopic papillary balloon dilation. (2003) (34)
Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. (2003) (34)
Large Isoform of Hepatitis Delta Antigen Activates Serum Response Factor-associated Transcription* (2000) (33)
Identification and characterization of a cytotoxic T cell epitope of hepatitis C virus presented by HLA-B*3501 in acute hepatitis. (1998) (33)
Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. (2004) (33)
Effect of acetaldehyde on collagen synthesis by fat-storing cells isolated from rats treated with carbon tetrachloride. (2008) (33)
In vivo Adenovirus‐mediated Prodrug Gene Therapy for Carcinoembryonic Antigen‐producing Pancreatic Cancer (1998) (33)
Pachydermoperiostosis associated with juvenile polyps of the stomach and gastric adenocarcinoma (2004) (32)
Identification of XAGE-1 isoforms: predominant expression of XAGE-1b in testis and tumors. (2007) (32)
Efficacy of clinical pathway for the management of mucosal gastric carcinoma treated with endoscopic submucosal dissection using an insulated-tip diathermic knife. (2004) (32)
Short-Term High-Dose Followed by Long-Term Low-Dose Hepatitis B Immunoglobulin and Lamivudine Therapy Prevented Recurrent Hepatitis B After Liver Transplantation (2007) (32)
Serum endostatin levels in patients with hepatocellular carcinoma. (2000) (32)
Hepatocellular carcinoma in elderly patients (2002) (32)
Coronary pressure measurement to determine treatment strategy for equivocal left main coronary artery lesions (2005) (31)
Frameshift Mutations at Mononucleotide Repeats in RAD50 Recombinational DNA Repair Gene in Colorectal Cancers with Microsatellite Instability (2001) (31)
Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival. (2002) (31)
HBcAg-Specific CD8 T Cells Play an Important Role in Virus Suppression, and Acute Flare-Up Is Associated with the Expansion of Activated Memory T Cells (2003) (31)
H. pylori decreases gastric mucin synthesis via inhibition of galactosyltransferase. (2003) (31)
Expression and immunogenicity of NY‐ESO‐1 in hepatocellular carcinoma (2006) (30)
Establishment of hepatitis C virus replicon cell lines possessing interferon-resistant phenotype. (2004) (30)
Endoscopic papillary balloon dilation for the management of common bile duct stones: Experience of 207 cases including high risk patients (1997) (30)
Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells. (2004) (30)
Modulation of KC/gro protein (interleukin-8 related protein in rodents) release from hepatocytes by biologically active mediators. (1994) (30)
Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma (2004) (30)
Hepatic stellate cell nomenclature. (1996) (30)
Role of macrophages in regeneration of liver (1996) (30)
Role of polymorphonuclear leukocytes in galactosamine hepatitis: Mechanism of adherence to hepatic endothelial cells (1994) (29)
Interferons specifically suppress the translation from the internal ribosome entry site of hepatitis C virus through a double-stranded RNA-activated protein kinase-independent pathway. (2002) (29)
Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies (2008) (29)
Inhibition of hepatic metastasis of colon carcinoma by asialo GM1–positive cells in the liver (1992) (28)
Weak Response of Helicobacter pylori Antibody Is High Risk for Gastric Cancer: a Cross-sectional Study of 10,234 Endoscoped Japanese (2002) (28)
Efficacy and safety of entecavir in nucleoside‐naive, chronic hepatitis B patients: Phase II clinical study in Japan (2009) (28)
Quantitative Analysis of ras Gene Mutation in Pancreatic Juice for Diagnosis of Pancreatic Adenocarcinoma (2004) (28)
Clinical features of Japanese male patients with type 1 autoimmune hepatitis (2006) (28)
A case of primary gastric choriocarcinoma and a review of the Japanese literature (1994) (27)
Small hyperechoic nodules in chronic liver diseases include hepatocellular carcinomas with low cyclin D1 and Ki‐67 expression (1999) (27)
A prospective and comparative cohort study on efficacy and drug resistance during long‐term lamivudine treatment for various stages of chronic hepatitis B and cirrhosis (2008) (27)
Prediction of the ablated area by the spread of microbubbles during radiofrequency ablation of hepatocellular carcinoma (2005) (27)
Long‐term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C (2000) (27)
Synergistic activation of the serum response element-dependent pathway by hepatitis B virus x protein and large-isoform hepatitis delta antigen. (2003) (27)
Interleukin-8 Production in Primary Cultures of Human Gastric Epithelial Cells Induced by Helicobacter pylori (1998) (27)
Different turnover rate of hepatitis C virus clearance by different treatment regimen using interferon-beta. (2000) (26)
Power Doppler signals after percutaneous ethanol injection therapy for hepatocellular carcinoma predict local recurrence of tumors: a prospective study using 199 consecutive patients. (2001) (26)
Modulation of collagen synthesis by fat-storing cells, isolated from CCl4-or vitamin A-treated rats (1987) (26)
Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course? (2000) (26)
Hepatocyte Nitric Oxide Production Is Induced by Kupffer Cells (1998) (26)
The polymerase L 528 M mutation cooperates with nucleotide binding-site mutations , increasing hepatitis B virus replication and drug resistance (2001) (26)
Gene expression profiling in biliary epithelial cells of primary biliary cirrhosis using laser capture microdissection and cDNA microarray. (2006) (25)
New Prognostic Scoring Model for Liver Transplantation in Patients with Non-Acetaminophen-Related Fulminant Hepatic Failure (2005) (25)
HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma. (2005) (25)
Long‐term monitoring of platelet count, as a non‐invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy (2006) (24)
Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate (1995) (24)
Clinical characteristics of synchronous colorectal cancer are different according to tumour location. (2007) (24)
Systemic inflammatory response syndrome strongly affects the prognosis of patients with fulminant hepatitis B (2007) (24)
Management of hepatocellular carcinoma: advances in diagnosis, treatment and prevention (2001) (24)
Quantitation of α‐fetoprotein and albumin messenger RNA in human hepatocellular carcinoma (1996) (23)
Suppressive effects of transforming growth factor-beta1 produced by hepatocellular carcinoma cell lines on interferon-gamma production by peripheral blood mononuclear cells. (2002) (23)
Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B (2009) (23)
Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma (2003) (23)
Different clinicopathological features of hepatocellular carcinoma in relation to causative agents (2001) (23)
Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting. (2006) (23)
Antigen presentation by Kupffer cells in the rat. (1984) (22)
Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma. (2002) (21)
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma. (1999) (21)
Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients. (2007) (21)
Activation of Cyclin E-Dependent Kinase Activity in Colorectal Cancer (2001) (21)
Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience (2009) (21)
Gene expressions associated with chemosensitivity in human hepatoma cells. (2007) (20)
Combination of 5-FU and IFNalpha enhances IFN signaling pathway and caspase-8 activity, resulting in marked apoptosis in hepatoma cell lines. (2006) (20)
Regression of hepatocellular carcinoma during vitamin K administration. (2005) (20)
Early detection of haemobilia associated with percutaneous ethanol injection for hepatocellular carcinoma (2000) (19)
Poor association of TT virus viremia with hepatocellular carcinoma. (2000) (19)
Factors affecting the prognosis of patients with hepatocellular carcinoma invading the portal vein--a retrospective analysis using 952 consecutive HCC patients. (2003) (19)
[Gene therapy for hepatocellular carcinoma]. (2001) (19)
Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophages. (1990) (18)
Quantity of mutant K-ras gene in pancreatic secretions for diagnosis of pancreatic carcinoma with different assays: analysis of 100 patients. (2002) (18)
Exon 2 deletion splice variant of γ‐glutamyl carboxylase causes des‐γ‐carboxy prothrombin production in hepatocellular carcinoma cell lines (2008) (18)
Dietary intake, neutrophil fatty acid profile, serum antioxidant vitamins and oxygen radical absorbance capacity in patients with ulcerative colitis. (2007) (17)
Hepatitis C virus core protein and hepatitis activity are associated through transactivation of interleukin-8. (2005) (17)
Cimetidine inhibits epidermal growth factor‐induced cell signaling (2007) (17)
Simple quantitative assay of alpha-fetoprotein mRNA in liver tissue using the real-time detection polymerase chain reaction assay - its application for clinical use. (2001) (17)
Cellular distribution of telomerase reverse transcriptase in human hepatocellular carcinoma (2003) (17)
Pneumocystis carinii pneumonia in patients with ulcerative colitis (2004) (17)
Increased release of KC/gro protein, intercrine cytokine family, from hepatocytes of the chronically ethanol fed rats. (1993) (17)
Power Doppler sonography for hepatocellular carcinoma: factors affecting the power Doppler signals of the tumors. (2008) (16)
Contrast-enhanced ultrasonography depicts small tumor vessels for the evaluation of pancreatic tumors. (2007) (16)
Serum Antibodies to Helicobacter pylori and its Heat‐Shock Protein 60 Correlate with the Response of Gastric Mucosa‐Associated Lymphoid Tissue Lymphoma to Eradication of H. pylori (2004) (16)
Oxygenation abnormalities in normoxemic patients with mild liver cirrhosis. (2002) (16)
Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer (2003) (15)
Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease duration (2008) (15)
Decreased expression of hMLH1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells. (2007) (15)
A case of primary follicular lymphoma in the duodenum confined to the mucosal layer. (2002) (15)
Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms (1991) (15)
Helicobacter pylori activates the proto-oncogene c-fos through SRE transactivation. (2002) (15)
Time‐dependent analysis of predisposing factors for the recurrence of hepatocellular carcinoma (2009) (15)
Difficulties in conducting controlled trials in radical therapies for nonadvanced hepatocellular carcinoma (2000) (14)
Effect of splenectomy on hepatic metastasis of colon carcinoma and natural killer activity in the liver (1995) (14)
High Viral Eradication with a Daily 12-Week Natural Interferon-β Treatment Regimen in Chronic Hepatitis C Patients with Low Viral Load (2000) (14)
Activation of cyclin D1-related kinase in human lung adenocarcinoma (1999) (14)
Prospective randomized controlled trial comparing percutaneous radiofrequency ablation and percutaneous ethanol injection therapy for small hepatocellular carcinoma (2000) (14)
IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways. (2005) (14)
Dissection of a refractory pancreatic-duct stricture by using a pre-cutting needle-knife. (2006) (13)
pp60c-src Activation in gastric carcinoma: a preliminary study (2000) (13)
Gene therapy for hepatic micrometastasis of murine colon carcinoma. (1998) (13)
Human leukocyte antigen DR status and clinical features in Japanese patients with type 1 autoimmune hepatitis (2008) (13)
A possible novel src-related tyrosine kinase in cancer cells of LEC rats that develop hepatocellular carcinoma. (2000) (13)
Real‐time monitoring of HCV‐RNA by single tube assay kit and potential importance for predicting virological sustained response in patients with chronic hepatitis C (1996) (13)
Quantitative real-time RT-PCR analysis of NY-ESO-1 and LAGE-1a mRNA expression in normal tissues and tumors, and correlation of the protein expression with the mRNA copy number. (2005) (13)
Clinical features of patients with HCC who are negative for both HBV and HCV markers. (2003) (13)
Phagocytic properties of hepatic endothelial cells and splenic macrophages compensating for a decreased phagocytic function of Kupffer cells in the chronically ethanol-fed rats. (1989) (13)
Coronary pressure measurement to identify the lesion requiring percutaneous coronary intervention in equivocal tandem lesions (2006) (13)
Analysis of factors influencing hepatocellular carcinoma detection: efficient use of computed tomography during arterial portography and during hepatic arteriography (2005) (12)
Therapeutic Efficacy of Leukocytapheresis in a Pregnant Woman with Severe Active Ulcerative Colitis (2006) (12)
Intrahepatic mRNA Levels of Type I Interferon Receptor and Interferon-Stimulated Genes in Genotype 1b Chronic Hepatitis C (2006) (12)
Relationship between nuclear factor‐κB activation and virulence factors of Helicobacter pylori in Japanese clinical isolates (2002) (12)
Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma (2005) (12)
Risk factors for high-grade dysplasia or carcinoma in colorectal adenoma cases treated with endoscopic polypectomy (2008) (12)
Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis. (2006) (12)
Cost-effectiveness of adjuvant interferon therapy after surgical resection of Hepatitis C-related hepatocellular carcinoma. (2002) (12)
Prognostic factors for fatal outcomes prior to receiving liver transplantation in patients with non‐acetaminophen‐related fulminant hepatic failure (2007) (12)
Percutaneous ethanol injection therapy for neoplasms located on the surface of the liver. (1990) (12)
Chemotactic factors released from hepatocytes exposed to acetaminophen (1995) (12)
Endoscopic therapy for bleeding esophageal varices improves the outcome of Child C cirrhotic patients (2006) (11)
Hepatitis B Virus Gene in Liver Tissue Promotes Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients (2003) (11)
Fibrosis progression rates between chronic hepatitis B and C patients with elevated alanine aminotransferase levels (2008) (11)
ADVANCES IN THE DEVELOPMENT OF A RELIABLE ASSAY FOR THE MEASUREMENT OF STOOL DECAY-ACCELERATING FACTOR IN THE DETECTION OF COLORECTAL CANCER (2002) (11)
Quantitative evaluation of telomerase activity in small liver tumors: analysis of ultrasonography-guided liver biopsy specimens. (1999) (11)
Does Pretreatment with Lansoprazole Influence Helicobacter pylori Eradication Rate and Quality of Life? (2010) (11)
Identification of risk factors for lymph node metastasis of colorectal cancer. (2007) (11)
Adult‐onset type II citrullinemia associated with idopathic hypertriglyceridemia as a preceding feature (2006) (11)
Release of decay-accelerating factor into stools of patients with colorectal cancer by means of cleavage at the site of glycosylphosphatidylinositol anchor. (2003) (11)
Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis. (2004) (11)
A randomized trial of 24 versus 48 weeks of peginterferon α-2a in patients infected with chronic hepatitis C virus genotype 2 or low viral load genotype 1: a multicenter national study in Japan (2009) (11)
Twenty‐four weeks of interferon α‐2b in combination with ribavirin for Japanese hepatitis C patients: sufficient treatment period for patients with genotype 2 but not for patients with genotype 1 (2006) (11)
Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseases. (2001) (11)
Anti-viral actions and viral dynamics in the early phase of three different regimens of interferon treatment for chronic hepatitis C: differences between the twice-daily administration of interferon-beta treatment and the combination therapy with interferon-alpha plus ribavirin. (2003) (11)
High viral eradication with a daily 12-week natural interferon-beta treatment regimen in chronic hepatitis C patients with low viral load. IFN-beta Research Group. (2000) (10)
Increased levels of tissue inhibitor of metalloproteinase‐1 in human hepatocellular carcinoma (2004) (10)
Sustained Viral Response Is Rarely Achieved in Patients with High Viral Load of HCV RNA by Excessive Interferon Therapy (2000) (10)
Rectosigmoid findings are not associated with proximal colon cancer: analysis of 6 196 consecutive cases undergoing total colonoscopy. (2005) (10)
A Crucial Role of Hepatocyte Nuclear Factor-4 Expression in the Differentiation of Human Ductular Hepatocytes (2003) (10)
Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesion (2007) (10)
Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma (2004) (10)
Activation of epidermal growth factor receptor kinase in gastric carcinoma: a preliminary study (2000) (10)
Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma (2004) (10)
4643 A prospective randomized study of “covered” vs “uncovered” metallic stent for distal malignant biliary obstruction. (2000) (9)
[A case of resected pancreatic metastasis from renal cell carcinoma 26 years after right nephrectomy]. (2006) (9)
Determination of the optimal cut‐off value for the [13C]‐urea breath test based on a Helicobacter pylori‐specific polymerase chain reaction assay (2000) (9)
Clarithromycin-based triple therapy for non-resistant Helicobacter pylori infection. How long should it be given? (2001) (9)
Percutaneous hepatic infarction therapy for hepatocellular carcinoma. (1998) (9)
Risk factors and indications for first surgery in Crohn's disease patients. (2007) (9)
Development of hepatocellular carcinoma in a woman with HBV- and HCV-negative autoimmune hepatitis with unsatisfactory response to Corticosteroid. (2005) (9)
Hepatocellular carcinoma depicted as hypoattenuation on CT hepatic arteriography (CTA) and hyperattenuation on CT during arterial portography (CTAP) (2001) (9)
Different clinicopathological features of hepatitis B- and C-related hepatocellular carcinoma. (1996) (9)
Role of platelet-activating factor in pathogenesis of galactosamine-lipopolysaccharide-induced liver injury (1996) (9)
[Percutaneous ethanol injection therapy for small hepatocellular carcinoma]. (1996) (9)
Relationship Between Grade of Microsatellite Instability and Target Genes of Mismatch Repair Pathways in Sporadic Colorectal Carcinoma (2001) (9)
Strategy of liver-directed gene therapy: present status and future prospects. (1999) (9)
Factors predisposing to poorly differentiated hepatocellular carcinoma and its recurrence. (2005) (8)
Age-related comparison of the profiles of patients with hepatocellular carcinoma. (2006) (8)
[A case of carcinosarcoma of the esophagus treated by the chemoradiotherapy]. (2007) (8)
Acquired factor VIII inhibitor in a non-hemophilic patient with chronic hepatitis C viral infection. (1999) (8)
Effects of pulsing procedure of interleukin-12 in combination with interleukin-2 on the activation of peripheral blood lymphocytes derived from patients with hepatocellular carcinoma. (2003) (8)
Modulation of the collagen synthesis by fat storing cells isolated from rats treated with carbon tetrachloride and vitamin a (1985) (8)
Risk factors for esophageal variceal bleeding in patients with hepatocellular carcinoma. (2002) (8)
Structure of cag pathogenicity island in Japanese and Western Helicobacter pylori isolates (1998) (7)
A prospective study of interferon therapy modified by pre-treatment viral load in cirrhotic patients. Tokyo-Chiba Hepatitis Research Group. (2000) (7)
A mechanism of accumulation and activation of polymorphonuclear cells and macrophages in the liver of alcoholics: production of chemotactic factor by hepatocytes exposed to ethanol. (1992) (7)
Multiple stenting in hilar bile duct carcinoma: three-branched partial stent-in-stent deployment with the JOSTENT SelfX. (2004) (7)
Anti-endostatin monoclonal antibody enhances growth of human hepatocellular carcinoma cells by inhibiting activity of endostatin secreted by the transplanted cells in nude mice. (2004) (7)
Effect of anti-allergic agents on chemotaxis of neutrophils by stimulation of chemotactic factor released from hepatocytes exposed to ethanol (1994) (7)
Stool decay‐accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis (2005) (7)
Enteral nutrition improves health-related quality of life in Crohn's disease patients with long disease duration. (2009) (7)
Outcome of small liver nodules detected by computed tomographic angiography in patients with hepatocellular carcinoma (2010) (7)
Does Mutation of Transforming Growth Factor-β Type II Receptor Gene Play an Important Role in Colorectal Polyps? (1999) (7)
Endotoxin induced cellular communication in the liver: Murine models for clarification of the role of LPS‐responsive macrophages in the pathogenesis of liver diseases (1995) (7)
Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus. (2004) (6)
"Duodenal intussusception" due to adenoma of the papilla of Vater. (2003) (6)
Efficacy and cost-effectiveness of consensus interferon monotherapy with high-dose induction for hepatitis C patients with genotype 2 (2011) (6)
Pitfall of Immunological Fecal Occult Blood Test; a Comparison with Total Colonoscopy (2004) (6)
Antral Red Streaking is a Negative Endoscopic Sign for Helicobacter Pylori Infection (2002) (6)
Endoscopic variceal ligation is a sufficient procedure for the treatment of oesophageal varices in patients with hepatitis C liver cirrhosis: Comparison with injection sclerotherapy (1999) (6)
Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis. (2004) (6)
Superoxide anion generating capacity and lysosomal enzyme activities of Kupffer cells in galactosamine induced hepatitis (1986) (6)
Helicobacter pylori activates NF-kB through a signaling pathway involving ikb kinases (IKKs), NF-KB-inducing kinase (NIK), TRAF2, and TRAF6 (2000) (6)
Simple and practical methods to study cag pathogenicity island: Usage of cagE and cagT gene amplification (1998) (6)
Peritoneal dissemination of hepatocellular carcinoma treated with a combination therapy of interferon-alpha-2b and oral tegafur/uracil. (2007) (6)
Hepatitis C virus genotypes: molecular basis and clinical significance. (1996) (5)
Cholestatic hepatocellular carcinoma diagnosed by deposits of Lipiodol and treated by combination of endoscopic retrograde biliary drainage and transcatheter arterial embolization (1992) (5)
High Level of Expression of α-Fetoprotein Receptor in Gastric Cancers (2006) (5)
A model for estimating cirrhosis in patients with type 1 autoimmune hepatitis (2008) (5)
Adenovirus mediated p 53 tumour suppressor gene therapy for human gastric cancer cells in vitro and in vivo (1999) (5)
Elevated levels of tissue inhibitor of metalloproteinases (TIMPS) in human hepatocellular carcinomas (2004) (5)
Cytoskeletal function of cultured kupffer cells during phagocytosis (1985) (5)
Percutaneous ethanol injection therapy for hepatocellular-carcinoma (review). (1993) (5)
High level of expression of alpha-fetoprotein receptor in gastric cancers. (2006) (4)
Centrifugal Leukocytapheresis Therapy for Ulcerative Colitis Without Concurrent Corticosteroid Administration (2006) (4)
Exponential-Exponential Cosine Fitting of Blood Pressure Decay by a Long-Acting Calcium Channel Blocker, Amlodipine, Using Home-Blood Pressure Measurement (2003) (4)
CONCURRENT GASTRIC AND COLONIC LOW‐GRADE MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMATA IN A PATIENT WITHOUT HELICOBACTER PYLORI INFECTION (2003) (4)
Progression from chronic hepatitis to hepatocellular carcinoma: Natural course and treatments (2002) (4)
A pregnant patient with fulminant hepatic failure was found to carry a novel missense mutation in the argininosuccinate synthetase gene (4)
Early detection and quantification of lamivudine-resistant hepatitis B virus mutants by fluorescent biprobe hybridization assay in lamivudine-treated patients (2006) (4)
Characterization of elongated Helicobacter pylori isolated from a patient with gastric-mucosa-associated lymphoid-tissue lymphoma. (2004) (4)
Sonographically guided percutaneous injection of ethanol for treatment of hepatocellular carcinoma: value of Gelfoam to mark the lesion. (1989) (4)
A Novel Chromoendoscopic Method By Using Acetic Acid-Indigo Carmine Mixture (AIM) for Diagnosis of Early Gastric Cancers (2006) (4)
Identification of genes associated with sensitivity to 5-fluorouracil and cisplatin in hepatoma cells (2002) (4)
Occurrence of antibody against rat hepatic sinusoidal endothelial cells in sera of patients with autoimmune hepatitis (1995) (4)
Lp3/Hapln3 Expression is Coordinately Upregulated with Versican in Balloon-injured Artery and is Enhanced by PDGF in Arterial Smooth Muscle Cell (Restenosis after Angioplasty, Basic/Clinical 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (3)
Early removal of bile duct stones in patients with acute biliary pancreatitis by endoscopic papillary balloon dilatation. (2004) (3)
Reversal of Protein-Losing Enteropathy with Heparin Therapy in an Adult Patient with Congenital Heart Disease (2007) (3)
Quantitative analysis of ras gene mutation in pancreatic secretions for diagnosis of pancreatic carcinoma: Comparison with three different assays (1998) (3)
How soon can a virological sustained response be determined after withdrawal of interferon therapy in chronic hepatitis C? (1999) (3)
Galactosyltransferase activities in human sera of various diseases. (1981) (3)
Intense response of heart rate with pronounced suppression of high-frequency power of heart rate variability to early morning exercise with high-intensity load. (2002) (3)
[Interluekin-1 beta genetic polymorphism influences the impact of cytochrome P 2C19 genotype on the cure rate of H. pylori eradication therapy]. (2004) (3)
Washout of small stones in the bile duct by saline infusion using a side-holed balloon catheter in patients undergoing endoscopic papillary balloon dilation. (1999) (3)
Current options for the therapy of chronic hepatitis B infection (2001) (3)
Generation of chemotactic factor by hepatocytes isolated from chronically ethanol-fed rats (1992) (2)
A monoclonal antibody to rat asialoglycoprotein receptor that recognizes an epitope specific to its major subunit. (2003) (2)
Influence of reverse transcriptase YMDD motif variants on replication and lamivudine resistance of hepatitis B virus (1998) (2)
pp60c-src activation in gastric carcinoma: a preliminary study. (2000) (2)
Novel Procedure of Endoscopic Submucosal Dissection (ESD) Using a New Device (Mucosectome) for Early Esophageal Cancer (2006) (2)
Circulating white blood cell count correlates with left ventricular indices independently of the extent of risk area for myocardial infarction after successful reperfusion (2004) (2)
Kupffer cells inhibit the lymphoproliferative response to antigenic stimulation by rat hepatocytes. (1983) (2)
Ultrasound-guided percutaneous injection of ethanolamine oleate for hypersplenism. An experimental study in dogs. (1990) (2)
[HCV-related hepatocellular carcinoma]. (2002) (2)
Development of an automatic Doppler flow signal detection system: variability of pulmonary and aortic peak flow velocity (2007) (2)
Adenovirus-mediated enzyme-prodrug therapy for cancer (1997) (2)
PEPPERMINT OIL SOLUTION ADMINISTRATION AND ACETIC ACID-ENHANCED METHOD FOR DEVICE OF ESD PROCEDURE (2006) (2)
Evaluation of covered metallic stents in malignant biliary stenosis--prominent effectiveness in gallbladder carcinoma. (2005) (2)
Paradoxical functions of alveolar macrophages from Calmette-Guérin bacillus-immunized rats. (1985) (2)
Significant correlation of recruitable coronary collateral blood flow determined by coronary wedge pressure with ST-segment elevation during coronary occlusion (2005) (2)
Predictive factors for dose modification and premature discontinuation of interferon plus ribavirin for adverse effects in Japanese patients with chronic hepatitis C (2003) (2)
Factors Associated with Local Recurrence and Incomplete Resection in Endoscopic Submucosal Dissection for the Treatment of Early Gastric Cancers (2006) (2)
Novel Procedure of Endoscopic Submucosal Dissection (ESD) Using a New Device (MUCOSECTOME) (2005) (1)
4638 Endoscopic papillary balloon dilation in cirrhotic patients for the management of common bile duct stones. (2000) (1)
Triple therapy with faropenem against drug-resistant Hericobacter pylori (2000) (1)
[Development of a detection system for Helicobacter pylori DNA in gastric juice]. (1996) (1)
Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activator (1997) (1)
Resolution of Liver Fibrosis in Hepatitis C Patients by Interferon Therapy and Prevention of Hepatocellular Carcinoma (2003) (1)
A case of radiation colitis improved with ecabet sodium enema (2005) (1)
AETIOPATHOGENESIS OF HEPATOCELLULAR CARCINOMA (1996) (1)
Superoxide anion generating capacity of polymorphonuclear cells in patients with liver cirrhosis (1986) (1)
Effects of interferon therapy on inhibition of hepatocellular carcinoma development in patients with chronic hepatitis C. (2000) (1)
[Translation stimulation and shut-off by HCV and viral multiplication]. (2004) (1)
Novel mechanism of neutrophil accumulation in the liver of alcoholics (1993) (1)
Endoscopic Submucosal Dissection (ESD) Against Early Gastric Cancer Using Modified Intra-Gastric Lifting Method with Re-Opening Clip Device (2005) (1)
512 Interferon alpha 8 and 2 show differential activation of apoptosis pathway and growth factor pathway in human hepatoma cell lines (2003) (1)
Coronary Flow Reserve after Coronary Intervention is Similar in Patients with Preserved Viability in Previous Myocardial Infarction and in Those with Angina Pectoris (2004) (1)
A New Procedure of En-Bloc Endoscopic Mucosal Resection (EMR) Using Improved Papillotomy Knife (MUCOSECTOME) (2004) (1)
Total Colonoscopy Is Necessary for Elderly People: Analysis of 16,085 Colonoscopy Cases (2005) (1)
Intraductal papillary mucinous adenocarcinoma of the bile ducts. (2006) (1)
Mechanism of accumulation of macrophages in galactosamine-induced liver injury: effect of lipoxygenase inhibitors on chemotaxis of spleen cells. (1992) (1)
Role of hepatic sinusoidal cells in hepatic injury and fibrosis in the liver (1993) (1)
In vitro sonographic evaluation of common bile duct stones and fragments with a high‐frequency microprobe (1999) (1)
Original contributionTesting of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer☆ (2003) (1)
Helicobacter pylori antibody responsiveness and prevalence of gastric cancer among 10,000 consecutive endoscoped Japanese individuals (1998) (1)
[Mechanism of immune surveillance against HBV infection]. (2004) (1)
Clinical importance of flat type early colorectal adenocarcinoma: Relationship between age, location, and shape of early colorectal carcinoma (2000) (1)
[Mechanisms of the immune surveillance against HCV infection]. (2004) (1)
Subject Index Vol. 74, 2006 (2007) (0)
OE-278 Low dose of Cerivastatin increased microvessel formation and induced angiogenesis in conjunction with attenuating antiangiogenic protein in rat myocardial infarction(Cardiovascular Pharmacology, Basic/Clinical 1 (H) : OE34)(Oral Presentation (English)) (2004) (0)
Contents, Vol. 47, 1985 (1985) (0)
Histological features of hepatocellular carcinoma correlate with local recurrence after percutaneous ethanol injection therapy (PEIT) (2000) (0)
Decay-accelerating factor as a surface marker for specialized columnar epithelium in Barrett's esophagus (2003) (0)
New retrieval balloon catheter with a blind top and proximal side hole for fine bile duct fragments produced by lithotripsy (1997) (0)
Rightside colorectal cancers are likely to give false negative test of fecal occult blood on the basis of screening total colonoscopy (2001) (0)
Des-γ-carboxy prothrombin is the most important predisposing factor of portal vein tumor thrombus (PVTT) in hepatocellular carcinoma (HCC) (1998) (0)
Detection of clarithromycin resistance by Helicobacter pylori 23S RRNA mutation; Clinical usage (1998) (0)
Metalloprotease ADAMTS-1 Was Rapidly Expressed by Endothalial Cells in Acute Myocardial Infarction and Its Quantitative Analysis by Real-Time PCR (2003) (0)
A case of adult Meckel's diverticulum with gastrointestinal bleeding (2003) (0)
Efficacy and Outcomes of Endoscopic Therapy for Biliary Complications After Duct-to-Duct Biliary Reconstruction in Adult Living-Donor Liver Transplantation (2006) (0)
Effect of genetic polymorphism of CYP2C19 on eradication of Helicobacter pylori with various triple therapies (2001) (0)
1255 High sensitivity and specificity of combinational usage of DES-gamma-carboxy prothrombin and alpha-fetoprotein for detecting hepatocellular carcinomas (2003) (0)
Thirty-Fourth Annual Meeting of the Japanese Society of Gastroenterology October 12–14, 1992, Utsunomiya, Japan (2007) (0)
Acute gastric inflammation in Mongolian gerbils depends on the status of cag pathogenicity island of Helicobacter pylori (2000) (0)
P.113 Anti-viral activity, histologic improvement and safety of entecavir in Japanese adult nucleoside-analogue naive patients with chronic hepatitis B infection: a phase 2 clinical trial (2006) (0)
Contents Vol. 27, 2006 (2006) (0)
Unexpectedly high mutational rate of K-ras codon 12 in the pancreatic juice of patients with pancreatic cyst; Analysis using preferential homoduplex formation assay (PCR-PHFA) (1998) (0)
Analysis of Factors Associated with Difficult Biliary Cannulation: Especially Regarding Post Operative Anatomical Factors (2006) (0)
Splenic ablation by percutaneous injection of ethanolamine oleate in dogs: A possible therapy for hypersplenism (1989) (0)
Helicobacter pylori induces SRE and c-fos activation through the ERK signaling pathway in gastric cancer cells (2001) (0)
Combined therapy of irradiation and percutaneous tumor ablation for hepatocellular carcinoma with portal venous invasion—A consecutive analysis of 53 patients (2001) (0)
Signals Induced by HCV Proteins (2003) (0)
Percutaneous infarction therapy (PIT) for hepatocellular carcinoma (HCC) (1998) (0)
Functional impairment of transforming growth factor-β-smad signaling pathway in colorectal, pancreatic, and gastric, but not hepatic cancer cell lines (2001) (0)
ESD Using New Device for Rectal Tumor (2005) (0)
Contrast-enhanced ultrasonograpny depicts small tumor vessels for the evaluation of pancreatic tumors (2007) (0)
Abstracts of selected papers presented at the 79th general meeting of the Japanese Society of Gastroenterology March 29–31, 1993, Kyoto, Japan (1991) (0)
Activation of cyclin E kinase in colorectal cancer (2000) (0)
Hepatic volumetry using computed tomography for planning percutaneous ablation of hepatocellular carcinoma (2000) (0)
Changes in escape rhythms several years after radiofrequency ablation of the atrioventricular junction combined with pacemaker implantation (2006) (0)
To what extent should one try to lower tumor markers in trating hepatocellular carcinoma (1998) (0)
Erratum: Sloughing of intraductal tumor thrombus of hepatocellular carcinoma after transcatheter chemoembolization causing obstructive jaundice and acute pancreatitis (Journal of Vascular and Interventional Radiology (2006) 17 (583-585)) (2006) (0)
498 Efficacy and safety of entecavir in Japanese adult patients with incomplete response to current lamivudine treatment: A phase II clinical trial (2006) (0)
[Evaluating the efficacy of interferon therapy on hepatitis C patients]. (2004) (0)
[Percutaneous tumor ablation therapy for the advanced stage of HCC]. (2000) (0)
Relationship between R-R Interval (RR-l) and Maximal-Flow-Velocity of Aorta as a Marker of Cardiac Performance in Patients with Chronic Non-Valvular Atrial Fibrillation (NVAF) (2003) (0)
Rectosigmoid findings correlate with proximal colon adenoma but not with proximal colon cancer: A study of 3285 consecutive cases examined by total colonoscopy (2001) (0)
Analysis of apoptotic and anti-apoptotic effects induced by Helicobacter pylori (2000) (0)
Rapid turnover rate of hepatitis C virus clearance by the twice-a-day treatment regimen using interferon-beta (2000) (0)
Evaluation of risks for stomach cancer (ERISC): Cross-sectional findings and the cohort-study protocol (2000) (0)
High prevalence of functional type IV secretion system for CagA protein in Japanese clinical Helicobacter pylori (2001) (0)
RESOLUTION OF LIVER FIBROSIS IN HEPATITIS C PATIENTS WITH INTERFERON : A NATIONAL SURVEY (2001) (0)
Hematogenous metastasis mechanism of the hepatoma cell. Detection of a metastatic cancer cell and future prospect. (1996) (0)
Therapy for advanced hepatocellular carcinoma with vessel invasion with combination of hepatic arterial infusion chemotherapy and conformal radiation focusing on vessel tumor thrombus (2003) (0)
Helicobacter pylori upregulates cyclin D1 expression through mapk pathway (2000) (0)
Subject Index Vol. 27, 2006 (2006) (0)
Osteogenic protein-1 reduces intercellular adhesion molecule-1 messenger RNA expression, infarct size and TUNEL-positive cardiomyocytes in ischemia/reperfusion rat hearts. (2003) (0)
Frequent frameshift mutations of the RAD50 recombinational DNA repair gene in colorectal cancers with microsatellite instability (2001) (0)
Resolution of Fibrosis in Hepatitis C Patients with Sustained Response to Interferon: Long-Term Effects of Interferon Therapy on Histological Improvement (2001) (0)
A case of malignant lymphoma in the liver treated by percutaneous ethanol injection therapy under peritoneoscopic observation (1991) (0)
FRS-078 ADAMTS-1, A Disintegrin And Metalloprotease with ThromboSpondin motifs-1, Is a Novel Hypoxic Immediate Gene Expressed by Endothelial Cells(NO and Cardiovascular System (H) : FRS10)(Featured Research Session (English)) (2004) (0)
Drinking and Smoking Habit, But Not Colonic Neoplasm, Is Associated with Diverticulosis: Analysis of 13,695 Consecutive Colonoscopy Performed Cases (2005) (0)
A multivariate analysis for reflux esophagitis in Japanese: Lower esophageal sphincter function or helicobacter pylori? (2000) (0)
Clarithromycin-resistant Helicobacter pylori infection is more prevalent in elder population in Japan (2000) (0)
Acid inhibits hepatocyte growth factor-induced restitution of esophageal epithelial cells but not gastric epithelial cells: A possible mechanism of Barrett's esophagus formation (1998) (0)
353 Des-gamma-carboxy prothrombin (DCP) promotes vascular endothelial cell proliferation and migration through VEGRFR2-PLCγ-MAPK signaling pathway (2006) (0)
1005 Estimating the benefit of interferon therapy for individual patients with chronic hepatitis (2003) (0)
Screening of new antivirals for wild-type hepatitis B virus and three lamivudine-resistant mutants (1999) (0)
Antegrade guidewire assistant endoscopic papillary balloon dilation (Combined percutaneous and endoscopic technique) for management of common bile duct stone (1997) (0)
Tumor markers represent clinical profiles of hepatocellular carcinoma (HCC) (2000) (0)
Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) (2001) (0)
Fourth International Symposium of the Japanese Society of Gastroenterology October 12–13, 1992, Utsunomiya, Japan (2007) (0)
Activation of STAT and MAPkinase pathway is associated with induction of apoptosis in human hepatoma cell lines by interferon alpha 8 of IFN alpha subtype (2003) (0)
Percutaneous radiofrequency ablation therapy with intrapleural infusion technique for hepatocellular carcinoma in the hepatic dome (2001) (0)
Modulation of Hepatic Sinusoidal Cell Function by Transduction of Genes in the Liver: Gene Therapy for Hepatic Micro-Metastasis (1999) (0)
Percutaneous ethanol injection therapy for patients with hepatocellular carcinoma (HCC) whose serum total bilirubin levels were 2.0 MG/DL or more (1998) (0)
[Function of Pit cells and physiopathology]. (1995) (0)
Subject Index, Vol. 47, 1985 (1985) (0)
[High risk group for development of hepatocellular carcinoma]. (2001) (0)
Improvement of Chemosensitivity Prediction by Transcriptional Profiling in Hepatoma Cells (2001) (0)
P.373 Fusion mRNA from HBV integrants in human hepatoma cell line is associated with hepatocellular carcinogenesis (2006) (0)
Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that conters the bacteria resistance to clarithromycin treatment (2001) (0)
Contents Vol. 81, 2010 (2010) (0)
Complete ablation of color doppler signals to evaluate response to treatment with percutaneous ethanol injection for hepatocellular carcinoma (1998) (0)
Fibroblast-like cells of disse's space express endoglin, TGF-β binding protein, in hepatocellular carcinoma (HCC) (2001) (0)
S1942 A Randomized Trial of Standard vs. Dose-Escalation Dosing of Ribavirin in Combination Therapy for Chronic Hepatitis C Patients with Genotype 1 and High Viral Load (2008) (0)
Color doppler signals after transcatheter arterial embolization (TAE) to evaluate response to treatment for hepatocellular carcinoma (HCC) (1998) (0)
Vitamin K 2 Administration Improves the Prognoses of Patients with Hepatocellular Carcinoma Presenting High Levels of Serum Des-γ-Carboxy Prothrombin (2004) (0)
Risk Factors of Colorectal Cancer (CRC) Are Different According to Age and Gender: A Hospital Based Analysis Using 3,372 Naive Patients Receiving Colonoscopy (CS) (2005) (0)
A homosexual Japanese man with acute hepatitis due to hepatitis B virus genotype ae, concurrent with amebic colitis. (2007) (0)
The Metallic Stent for the Patients with Malignant Biliary Stenosis Induced By Advanced Pancreatic Cancer - Covered Stent Or Uncovered Stent in Chemotherapy Cases? (2006) (0)
Rescuing TGFb-Smad signalling pathway restores growth inhibition by TGFb in pancreatic cancer cells (2000) (0)
OE-312 Vasl1 (Vascular Link Protein-1) Is a Novel Extracellular Matrix Protein Limited To Vessels and Is Upregulated in Pressure Overload Heart(Hypertension, Basic 3 (H) : OE39)(Oral Presentation (English)) (2004) (0)
Percutaneous ethanol injection therapy for large hepatocellular carcinoma A long-term result (1997) (0)
Two-MM reconstructed CT as a routine tool for diagnosis of small hepatocellular carcinoma (HCC) (2000) (0)
Prospective study of interferon (IFN) therapy for compensated cirrhotic patients with chronic hepatitis, c by monitoring serum hepatitis of virus (HCV) RNA (1998) (0)
The size of colorectal adenomas as a risk factor for colorectal cancers (2000) (0)
Decreased expression of hMLH 1 correlates with reduced 5-fluorouracil-mediated apoptosis in colon cancer cells (0)
[Percutaneous hepatic infarction therapy (PIT)]. (2001) (0)
Predicting Factors for Long Term Effect of Leukocytapheresis (LCAP) in Ulcerative Colitis Patients (2006) (0)
Fourth International Symposium of the Japanese Society of Gastroenterology October 12–13, 1992, Utsunomiya, Japan (2007) (0)
[Structure and function of the internal ribosome entry site of HCV]. (2004) (0)
Contents Vol. 74, 2006 (2007) (0)
Eradication of Helicobacter pylori with one week dual therapy depend on metabolism of CYP2C19 (2000) (0)
Re-appearance of power Doppler signals in the tumor nodules of hepatocellular carcinoma after transarterial embolization reflects residual viable tumor cells: histological confirmation. (2004) (0)
Endoscopic Deployment of Jostent Selfx for Malignant Hilar Biliary Stricture: A Pilot Study (2005) (0)
Rightside shift in the distribution of colorectal adenomas occurs with aging (2001) (0)
Direct contact with Helicobacter pylori induced AP-1 transactivation through the ERK signaling pathway in gastric cancer cells (2000) (0)
Successful combination therapy of interferon-alpha (IFN-α) with lamivudine in IFN-resistant chronic hepatitis B (2003) (0)
Heat shock protein 60 of Helicobacter pylori induces inflammatory responses through the toll-like receptor-triggered pathway in cultured human gastric epithelial cells (2003) (0)
Non-invasive assessment of fibrosis resolution/progression in chronic hepatitis C patients who received anti-viral therapy (2003) (0)
Unique clinical profiles of patients with hepatocellular carcinoma less than 50 years old (2000) (0)
[HCV proteins suppress translation]. (2001) (0)
Prospective analysis of the origin of increased serum amylase after ERCP: Half cases of asymptomatic hyperamylasemia are not due to pancreas (2001) (0)
Percutaneous Ethanol Injection Therapy, Percutaneous Infarction Therapy, and Percutaneous Microwave Coagulation Therapy for Hepatocellular Carcinoma (2000) (0)
[Immunological abnormalities in ulcerative colitis]. (1982) (0)
Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyl-transferase gene sensitizes cancer cells to low concentration of 5-fluorouracil: A new way to overcome the resistance of chemotherapeutic agent (1998) (0)
chronic hepatitis C carcinoma prevention for individual patients with Benefit of interferon therapy in hepatocellular (2004) (0)
Association of Hla-Dq genes with susceptibility of Helicobacter pylori eradication therapy in patients with gastric MALT lymphoma (2003) (0)
Risk Factors of Lymph Node Metastasis of Colorectal Cancer; Analysis of 2502 Consecutive Cases Detected with Colonoscopy (2006) (0)
Chronic Renal Failure as a Risk of Colorectal Neoplasia (2005) (0)
Recurrence of hepatitis C virus-related hepatocellular carcinoma increases with severity of liver fibrosis - a prospective analysis of 221 consecutive patients- (2000) (0)
Short half-life of serum anti-CagA antibody: Comparison with conventional anti-Helicobacter pylori antibody (1998) (0)
Increase in Connective Tissue Growth Factor (CTGF) Expression Precedes Extrracellular Matrix (ECM) Gene Expressions in Pressure-overload Heart in Rats (Hypertension, Basic 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society) (2005) (0)
Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinoma. (2000) (0)
Posters (2004) (0)
Clinical evaluation of three-dimensional (3D) power Doppler ultrasonography for depiction of hepatocellular carcinoma (HCC) compared with angiography (2000) (0)
Complete difference of hepatocyte growth factor expression by ecabet sodium between in the presence and absence of Helicobactor pylori in stomach (1998) (0)
Late Reperfusion Enhanced Gelatinolysis in Infarct Periphreral Zone : Analysis by in Situ Zymogram Analysis in Rats (2003) (0)
99 Anti-mitochondrial IGA antibody induces apoptosis to MDCK cells bearing human polymeric immunoglobulin receptor: evidence for AMA induced immunopathology (2003) (0)
Relationship between the age and the site distribution of colorectal cancer (1998) (0)
Optimal duration for triple therapy against non-resistant strains of Helicobacter pylori (2000) (0)
Diagnostic value of contrast ultrasonography using pulse inversion harmonic imaging in the evaluation of hepatocellular carcinoma. A comparison with CT during hepatic arteriography (2001) (0)
7187 Prospective analysis of the clinical features of patients with streaky erythema in the antrum: a negative endoscopic sign for helicobactor pyroli infection. (2000) (0)
Does Treatment of Endoscopic Therapy for Esophageal Varices Improve Child C Cirrhosis Patient's Prognosis? (2004) (0)
Removal of Bile Duct Stones with Endoscopic Papillary Balloon Dilation (EPBD) ; A Case of Billroth II Gastrectomy with Cirrhosis and Hepatoceller Carcinoma (1998) (0)
Clinical features of large sessile colorectal polyps with a nodule-aggregated appearance (1998) (0)
[Japanese clinical statistical data of patients with protein-losing enteropathy]. (1992) (0)
Quantitative analysis of ras gene mutation in specimens obtained by EUS-FNA and ERCP for diagnosis of pancreatic carcinoma (2000) (0)
Epithelialization stimulants induce expression of vascular endothelial growth factor in human gastric epithelial cells in primary culture (1998) (0)
Subject Index, Vol. 57, 1989 (1989) (0)
Hepatic sinusoidal cell. prospect of advance and future of research. (1999) (0)
Target gene therapy for alpha-fetoprotein producing hepatocellular carcinoma by E1B55k-attenuated adenovirus (2001) (0)
PJ-065 Increments of serum chemokine interferon-gamma inducible protein 10 (IP-10) levels correlated with left ventricular function in acute myocardial infarction patients(Acute Myocardial Infarction, Clinical (Pathophysiology) 3 (IHD) : PJ11)(Poster Session (Japanese)) (2004) (0)
Digestive system and immunity. Recent advances. Disease state and functions of Pit cells. (1995) (0)
IL-8 response by Japanese Helicobacter pylori strains with different cag pathogenicity island structures (1998) (0)
Distinct mechanism of helicobacter pylori-mediated NF-κB activation between gastric cancer cells, MKN45 and monocystic cells, THP-1 (2001) (0)
Bilateral stenting and covered self-expandable metallic stent improve the patency in the patients with malignant biliary obstruction (2003) (0)
Papillary structure is not affected by endoscopic papillary balloon dilation (1998) (0)
The evaluation of putative virulence factors of helicobacter pylori for gastroduodenal disease in Mongolian gerbils (2001) (0)
Reductions of PDGF and TIMP-1 concentrations in serum contribute to resolutions of fibrosis in chronic hepatitis C patients with sustained response to interferon (IFN) therapy (2001) (0)
The causes of mortality in patients with hepatocellular carcinoma are different between hepatitis B virus-related and hepatitis C virus-related Hcc (2003) (0)
Role of hepatic sinusoidal cells in the pathogenesis of hepatocyte damage (1994) (0)
Endothelial Cells of Newly Formed Vessels in the Border Zone of Myocardial Infarction Express Proteoglycan Decorin and Biglycan (2003) (0)
Induction of Proliferation-Related Signals by Hepatitis C Virus (2002) (0)
[Determination of hepatitis B surface antigen subtypes]. (2004) (0)
Subject Index, Vol. 60, 1960 (1992) (0)
Combination therapy of percutaneous radiofrequency ablation after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma provides larger coagulation areas (2003) (0)
A caution to use tumor markers in assessing therapeutic effects of hepatocellulular carcinoma (HCC) (2000) (0)
[Genetic diagnosis of viral hepatitis]. (1999) (0)
Serial change of histelogical features after radiofrequency ablation (RFA) for hepstocellular carcinoma (HCC) (2001) (0)
[Correlation between the grade of immune response against hepatitis C virus (HCV) infection and MHC class II polymorphisms]. (2004) (0)
Roles of Antiviral Therapy in Chronic Hepatitis C Patients Should be Different According to the Stages of Liver Disease Progression (2004) (0)
Early detection of hemobilia following percutaneous ethanol injection therapy for hepatocellular carcinoma: “Hemobilia sign” of gallbladder (1998) (0)
[A case of ulcerative colitis successfully treated with low-dose warfarin for portal vein thrombosis after colectomy]. (2005) (0)
[Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation]. (2004) (0)
Case-control study of Lamivudine treatment in patients with HBV cirrhosis (2003) (0)
300 Des-gamma-carboxy prothrombin is an autologous growth factor for hepatocellular carcinoma (2006) (0)
Resolution of hepatic fibrosis as a consequence of interferon therapy for hepatitis C (2003) (0)
Heterogeneity of hepatic natural killer cells after administration of biological response modifier (BRM) (1993) (0)
Abstracts of selected papers presented at the 34th annual meeting of the Japanese Society of Gastroenterology October 12–14, 1992, Utsunomiya, Japan (1993) (0)
279 Novel splicing variant of the vitamin k-dependent γ-glutamyl carboxylase (GGCX) causes des-gamma-carboxyl prothrombin production in human hepatocellular carcinoma cell lines (2006) (0)
[Preventive use of interferons for liver neoplasms]. (1995) (0)
Subject Index Vol. 81, 2010 (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Yasushi Shiratori?

Yasushi Shiratori is affiliated with the following schools: